Does Ozurdex affect perfusion status in vein occlusion?
1 October 2018
| Eulee Seow
|
Cataract and Refractive
|
intravitreal dexamethasone implant, peripheral nonperfusion, retinal vein occlusion, wide-field fluorescein angiography
Ozurdex (intravitreal dexamethasone implant) has been approved by National Institute of Health & Care Excellence (NICE) for treatment of patients with macular oedema associated with vein occlusion. This study looks at the change in peripheral perfusion status in patients with...